https://allyxthera.com/ 2025-12-10T22:21:40+00:00 https://allyxthera.com/news-and-events/ 2024-12-05T18:50:32+00:00 https://allyxthera.com/about-us/ 2025-08-05T19:16:43+00:00 https://allyxthera.com/our-science/ 2024-12-05T19:12:53+00:00 https://allyxthera.com/our-approach/ 2023-04-07T17:39:43+00:00 https://allyxthera.com/careers/ 2024-12-05T18:51:12+00:00 https://allyxthera.com/contact/ 2024-12-05T18:51:53+00:00 https://allyxthera.com/news-and-events-v2/ 2023-10-19T20:10:15+00:00 https://allyxthera.com/allyx-therapeutics-announces-successful-completion-of-two-additional-studies-of-lead-candidate-alx-001/ 2025-12-10T22:22:00+00:00 https://allyxthera.com/allyx-therapeutics-awarded-3-3-million-nih-grant-to-support-further-clinical-studies-of-lead-candidate-alx-001/ 2024-10-15T12:27:28+00:00 https://allyxthera.com/allyx-therapeutics-announces-first-parkinsons-disease-patient-treated-with-alx-001/ 2024-09-04T13:46:00+00:00 https://allyxthera.com/neurology-live-synapse-targeting-agent-alx-001-ready-for-phase-2-following-early-stage-progressneurology-live-on-first-patient-treated/ 2024-07-09T20:30:29+00:00 https://allyxthera.com/allyx-therapeutics-announces-first-alzheimers-disease-patient-treated-with-lead-compound-alx-001/ 2024-06-11T12:08:03+00:00 https://allyxthera.com/809-2/ 2024-04-04T18:40:25+00:00 https://allyxthera.com/allyx-in-neurologylive-potential-of-mglur5-modifier-alx-001-in-neurodegenerative-disorders/ 2024-04-04T18:35:37+00:00 https://allyxthera.com/allyx-therapeutics-announces-positive-phase-1b-multiple-ascending-dose-data-and-advances-alx-001-to-patients/ 2024-04-04T18:40:45+00:00 https://allyxthera.com/allyx-therapeutics-announces-expansion-into-parkinsons-disease-clinical-research-with-lead-compound-alx-001-following-ind-acceptance/ 2024-04-04T18:39:50+00:00 https://allyxthera.com/yales-adam-mecca-md-phd-discusses-alx-001-with-neurologylive/ 2024-04-04T16:49:28+00:00 https://allyxthera.com/allyx-sets-phase-ii-plans-for-ad-in-motion-after-phase-ia/ 2023-10-31T14:48:01+00:00 https://allyxthera.com/728-2/ 2024-04-04T18:48:14+00:00 https://allyxthera.com/ctad-press-release/ 2024-04-04T18:47:53+00:00 https://allyxthera.com/nia-small-business-showcase-allyx-therapeutics-inc/ 2023-10-18T17:54:27+00:00 https://allyxthera.com/bristol-myers-drug-candidate-repairs-neuronal-damage-in-alzheimers-mouse-models/ 2023-10-18T17:54:50+00:00 https://allyxthera.com/allyx-bms-yale-announce-license-agreement/ 2023-10-18T17:55:12+00:00 https://allyxthera.com/drug-restores-cells-and-memories-in-alzheimers-mouse-models/ 2023-10-18T17:55:28+00:00 https://allyxthera.com/yale-discovery-could-lead-to-alzheimers-drug-restored-memory/ 2023-10-18T17:55:42+00:00